BellRing Brands (BRBR) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
5 May, 2026Executive summary
Second quarter net sales increased 2% year-over-year to $598.7 million, driven by higher Premier Protein volumes but offset by lower average selling prices, increased promotional activity, and an $11.3 million inventory-related charge.
Operating profit declined 31% year-over-year to $66.0 million, with net earnings down 42% to $33.9 million, reflecting higher costs, lower margins, and increased advertising expenses.
Adjusted EBITDA for Q2 was $53.8 million (9% margin), down significantly from the prior year, due to margin pressures from input cost inflation, unfavorable price/mix, and higher freight.
The company continues to invest in advertising and long-term growth despite a challenging promotional and inflationary environment.
Premier Protein and Dymatize brands maintained leading market share and household penetration in the RTD category.
Financial highlights
Q2 net sales were $598.7–$599 million, up 2% year-over-year; Premier Protein net sales grew 1.7%, Dymatize sales declined 2%.
Gross profit for Q2 was $161.7 million (27.0% of net sales), down from $189.8 million (32.3%) year-over-year; adjusted gross profit was $136 million (22.7%).
Adjusted EBITDA was $53.8–$54 million, with a margin of 9%, down 400 basis points from guidance.
SG&A expenses were $91.5–$92 million (15.3% of sales), with advertising investment up 140 basis points as a percentage of sales.
Net earnings per diluted share were $0.29 for Q2, compared to $0.45 last year; adjusted diluted EPS was $0.14, down from $0.53.
Outlook and guidance
Fiscal year 2026 net sales outlook is $2.325–$2.365 billion, with adjusted EBITDA guidance of $315–$335 million (approx. 14% of net sales).
Full-year 2026 net sales growth expected to be flat to up 2%, with adjusted EBITDA margin outlook at 14% (including 50 bps from the Q2 inventory charge).
Second half net sales growth anticipated at 1%, with Q3 net sales expected to decline ~1% and Q3 adjusted EBITDA margin projected at 16%.
Guidance incorporates ongoing promotional and consumer headwinds, incremental inflation, and continued investment in advertising.
Management expects to generate positive cash flows from operations over the next twelve months and believes liquidity and borrowing capacity are sufficient.
Latest events from BellRing Brands
- Net sales up 1%, earnings down 43%, wellness grew 7%, CEO transition and settlements announced.BRBR
Q1 202613 Apr 2026 - All proposals passed with strong support and no shareholder questions were raised.BRBR
AGM 20263 Feb 2026 - Q3 net sales up 16% and net earnings up 66%, prompting raised guidance and share buybacks.BRBR
Q3 20242 Feb 2026 - Double-digit sales and EBITDA growth driven by Premier Protein; 2025 outlook strong.BRBR
Q4 202413 Jan 2026 - Q1 net sales up 24% and net earnings up 75%, with FY25 outlook raised on Premier Protein strength.BRBR
Q1 20258 Jan 2026 - Virtual annual meeting to vote on directors, auditor, and executive pay; online access promoted.BRBR
Proxy Filing16 Dec 2025 - Virtual meeting to elect directors, ratify auditor, and approve pay, with focus on governance and ESG.BRBR
Proxy Filing16 Dec 2025 - Growth driven by brand strength, innovation, and retail expansion, with margin recovery expected.BRBR
Morgan Stanley Global Consumer & Retail Conference 20253 Dec 2025 - Board declassification, strong results, and enhanced ESG lead key 2025 proxy votes.BRBR
Proxy Filing1 Dec 2025